Canada Stem Cells Market Size & Outlook, 2024-2030
Canada stem cells market, 2018-2030 (US$M)
Related Markets
Canada stem cells market highlights
- The Canada stem cells market generated a revenue of USD 1,779.9 million in 2024 and is expected to reach USD 3,279.4 million by 2030.
- The Canada market is expected to grow at a CAGR of 10.7% from 2025 to 2030.
- In terms of segment, adult stem cells was the largest revenue generating product in 2024.
- Induced Pluripotent Stem Cells is the most lucrative product segment registering the fastest growth during the forecast period.
Stem cells market data book summary
| Market revenue in 2024 | USD 1,779.9 million |
| Market revenue in 2030 | USD 3,279.4 million |
| Growth rate | 10.7% (CAGR from 2024 to 2030) |
| Largest segment | Adult stem cells |
| Fastest growing segment | Induced Pluripotent Stem Cells |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Very Small Embryonic Like Stem Cells |
| Key market players worldwide | Thermo Fisher Scientific Inc, STEMCELL Technologies, CellGenix, PromoCell GmbH, Takara Bio Inc, Lonza Group Ltd, ATCC, Bio-Techne Corp |
Other key industry trends
- In terms of revenue, Canada accounted for 10.8% of the global stem cells market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. stem cells market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 3,279.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Stem Cells Market Scope
Stem Cells Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada stem cells market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to stem cells market will help companies and investors design strategic landscapes.
Adult stem cells was the largest segment with a revenue share of 83.4% in 2024. Horizon Databook has segmented the Canada stem cells market based on adult stem cells, human embryonic stem cells, induced pluripotent stem cells, very small embryonic like stem cells covering the revenue growth of each sub-segment from 2018 to 2030.
Canadian Institutes of Health Research (CIHR) is the major federal agency that provides funding for stem cell research in Canada. This country is expected to register substantial growth in the coming years owing to recent changes in guidelines for stem cell research by the International Society for Stem Cell Research (ISSCR).
Furthermore, Assisted Human Reproduction Act has been enacted for all research concerned with assisted human reproduction including the use of SCs for research or other applications. The availability of funds for conducting research advances in stem cell research and permissions to research human-embryo-derived stem cells is expected to boost market growth.
Reasons to subscribe to Canada stem cells market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada stem cells market databook
-
Our clientele includes a mix of stem cells market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada stem cells market , including forecasts for subscribers. This country databook contains high-level insights into Canada stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada stem cells market size, by product, 2018-2030 (US$M)
Canada Stem Cells Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
